Objective:
To investigate a possible correlation between chromosomal aberrations and paternal age, analyzing embryos derived from young oocyte donors, with available preimplantation genetic testing for aneuploidy results from day 5/6 trophectoderm biopsy obtained by next-generation sequencing for all 24 chromosomes.
Design:
Retrospective cohort study.
Setting:
Canadian fertility centre.
Patient(s):
A total of 3,118 embryos from 407 male patients, allocated into three paternal age groups: group A, ≤39 years (n = 203); group B, 40-49 years (n = 161); group C, ≥50 years (n = 43).
Intervention(s):
None.
Main Outcome Measure(s):
The primary outcomes were aneuploidy, euploidy, mosaicism, and blastocyst formation rates. Secondary endpoints were comparison of specific chromosome aneuploidy, segmental and complex (involving two chromosomes + mosaicism >50%) aneuploidy, and analysis of overall percentage of chromosomal gains and losses within each group.
Result(s):
The study included 437 in vitro fertilization (IVF) antagonist cycles using 302 oocyte donors in which preimplantation genetic testing for aneuploidy was performed. Overall, 70.04% of embryos were euploid, 13.9% were aneuploid, and 16.06% were mosaic. No significant differences among paternal age groups A, B, and C were found in euploidy rates (69.2%, 70.6%, 71.4%, respectively), aneuploidy rates (14.7%, 12.8%, 13.9%, respectively) or mosaicism rates (16.1%, 16.6%, 13.6%; respectively). The fertilization rate was lower in group C compared with group B (76.35% vs. 80.09%). No difference was found in blastocyst formation rate between the study groups (median 52% [interquartile range, 41%, 67%] vs. 53% [42%, 65%] vs. 52% [42%, 64%], respectively). A generalized linear mixed model regression analysis for embryo ploidy rates found older oocyte donor age to be independently associated with embryo aneuploidy (odds ratio = 1.041; 95% CI, 1.009-1.074). The rate of segmental aneuploidies was significantly higher in the older versus younger paternal age group (36.6% vs. 19.4%).
Conclusion(s):
No association was found between paternal age and aneuploidy rates in embryos derived from IVF cycles using young oocyte donors, after adjusting for donor, sperm, and IVF cycle characteristics. Advanced paternal age ≥ 50, compared with younger paternal ages, was associated with a lower fertilization rate and increased rate of segmental aberrations.
Citing Articles
The impact of advanced paternal age on the live birth rate in patients undergoing Assisted Reproduction treatment: Findings from an analysis at a public reproductive center in Brazil.
Maia V, Rodrigues A, Sousa V, Barcelos M, Goulart J, Paulini F
JBRA Assist Reprod. 2024; 28(4):650-657.
PMID: 39254471
PMC: 11622406.
DOI: 10.5935/1518-0557.20240053.
Livebirth rates are influenced by an interaction between male and female partners' age: analysis of 59 951 fresh IVF/ICSI cycles with and without male infertility.
Datta A, Campbell S, Diaz-Fernandez R, Nargund G
Hum Reprod. 2024; 39(11):2491-2500.
PMID: 39241250
PMC: 11532605.
DOI: 10.1093/humrep/deae198.
The impact of paternal age on cumulative assisted reproductive technology outcomes.
Farabet C, Pirtea P, Benammar A, de Ziegler D, Marchiori C, Vallee A
Front Med (Lausanne). 2024; 10:1294242.
PMID: 38298503
PMC: 10828963.
DOI: 10.3389/fmed.2023.1294242.
Advanced Paternal Age: A New Indicator for the Use of Microfluidic Devices for Sperm DNA Fragmentation Selection.
Escude-Logares L, Serrano-Novillo C, Uroz L, Galindo A, Marquez C
J Clin Med. 2024; 13(2).
PMID: 38256591
PMC: 10816896.
DOI: 10.3390/jcm13020457.
Y chromosome AZFc microdeletion may have negative effect on embryo euploidy: a retrospective cohort study.
Jiang W, Xie Q, Li X, Yang Y, Luan T, Ni D
BMC Med Genomics. 2023; 16(1):324.
PMID: 38082270
PMC: 10712062.
DOI: 10.1186/s12920-023-01760-z.
Polyamines in Ovarian Aging and Disease.
Kang B, Wang X, An X, Ji C, Ling W, Qi Y
Int J Mol Sci. 2023; 24(20).
PMID: 37895010
PMC: 10607840.
DOI: 10.3390/ijms242015330.
Obstetrical and Perinatal Outcomes Are Not Associated with Advanced Paternal Age in IVF or ICSI Pregnancies with Autologous Oocytes.
Navarro-Gomezlechon A, Gil Julia M, Pacheco-Rendon R, Hervas I, Mossetti L, Rivera-Egea R
Biology (Basel). 2023; 12(9).
PMID: 37759655
PMC: 10525525.
DOI: 10.3390/biology12091256.
Factors associated with embryo mosaicism: a systematic review and meta-analysis.
Cascales A, Morales R, Castro A, Ortiz J, Lledo B, Ten J
J Assist Reprod Genet. 2023; 40(10):2317-2324.
PMID: 37592098
PMC: 10504166.
DOI: 10.1007/s10815-023-02914-9.
Fertility preservation in pediatric healthcare: a review.
Chen L, Dong Z, Chen X
Front Endocrinol (Lausanne). 2023; 14:1147898.
PMID: 37206440
PMC: 10189781.
DOI: 10.3389/fendo.2023.1147898.
Correlation study of male semen parameters and embryo aneuploidy in preimplantation genetic testing for aneuploidy.
Yang H, Liu Y, Niu W, Yang Z, Wang Y, Jin H
Front Endocrinol (Lausanne). 2023; 13:1072176.
PMID: 36778601
PMC: 9908608.
DOI: 10.3389/fendo.2022.1072176.
Advanced Paternal Age Does Not Affect Medically-Relevant Obstetrical and Perinatal Outcomes following IVF or ICSI in Humans with Donated Oocytes.
Navarro-Gomezlechon A, Gil Julia M, Hervas I, Mossetti L, Rivera-Egea R, Garrido N
J Clin Med. 2023; 12(3).
PMID: 36769665
PMC: 9918020.
DOI: 10.3390/jcm12031014.
Reproductive axis ageing and fertility in men.
Martins da Silva S, Anderson R
Rev Endocr Metab Disord. 2022; 23(6):1109-1121.
PMID: 36322295
PMC: 9789007.
DOI: 10.1007/s11154-022-09759-0.
Application of machine learning to predict aneuploidy and mosaicism in embryos from in vitro fertilization cycles.
Ortiz J, Morales R, Lledo B, Vicente J, Gonzalez J, Garcia-Hernandez E
AJOG Glob Rep. 2022; 2(4):100103.
PMID: 36275401
PMC: 9574883.
DOI: 10.1016/j.xagr.2022.100103.
TEffect of Single Embryo Blastomere Biopsy from Human Frozen Embryos on Assisted Reproductive Outcomes.
Aghajani S, Salehzadeh A, Ghasemian F, Mehrafza M, Hosseini A
Cell J. 2022; 24(10):628-636.
PMID: 36259481
PMC: 9617026.
DOI: 10.22074/cellj.2022.8328.
A Mini-Review Regarding the Clinical Outcomes of In Vitro Fertilization (IVF) Following Pre-Implantation Genetic Testing (PGT)-Next Generation Sequencing (NGS) Approach.
Doroftei B, Ilie O, Anton N, Armeanu T, Ilea C
Diagnostics (Basel). 2022; 12(8).
PMID: 36010262
PMC: 9406843.
DOI: 10.3390/diagnostics12081911.
Is paternal age associated with transfer day, developmental stage, morphology, and initial hCG-rise of the competent blastocyst leading to live birth? A multicenter cohort study.
Buhl Borgstrom M, Grondahl M, Klausen T, K Danielsen A, Thomsen T, Bentin-Ley U
PLoS One. 2022; 17(7):e0270664.
PMID: 35901038
PMC: 9333207.
DOI: 10.1371/journal.pone.0270664.
OBGYN providers' lack of knowledge and management of genetic risks due to advanced paternal age underscore the need for updated practice guidance.
Biddle J, Wetherill L, Geddes G, Quirin K, Rouse C, Hines K
J Community Genet. 2022; 13(4):427-433.
PMID: 35715593
PMC: 9314482.
DOI: 10.1007/s12687-022-00595-y.
Ovarian Aging: Molecular Mechanisms and Medical Management.
Tesarik J, Galan-Lazaro M, Mendoza-Tesarik R
Int J Mol Sci. 2021; 22(3).
PMID: 33573050
PMC: 7866420.
DOI: 10.3390/ijms22031371.